ClassID:

110523

C12N2750/14043 - CPC Classification

Classification description:

ssDNA viruses; Details; Parvoviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Recent Application in this class:
#1
20260049315
2026-02-19

SOD1 DUAL EXPRESSION VECTORS AND USES THEREOF

#2
20250381308
2025-12-18

AAV-MEDIATED EXPRESSION USING A SYNTHETIC PROMOTER AND ENHANCER

#3
20250281603
2025-09-11

Compositions for the Treatment of Infectious Disease Related Complications and Methods Thereof

#4
20250277236
2025-09-04

VIRUS-DERIVED CONSTRUCT PLASMID LIBRARY AND CONSTRUCTION OF SAME

#5
20250228974
2025-07-17

MODULATION OF NEURAL PATHWAYS

#6
20250223612
2025-07-10

ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN INTERNEURONS

#7
20250171806
2025-05-29

ENGINEERED VIRAL VECTORS WITH ENHANCED PACKAGING CAPACITY AND METHODS OF USING THE SAME

#8
20250154511
2025-05-15

Products and Methods for Treatment of Amyotrophic Lateral Sclerosis

#9
20240344071
2024-10-17

Products and Methods for Treatment of Amyotrophic Lateral Sclerosis

#10
20240254513
2024-08-01

VIRAL VECTOR PRODUCTION SYSTEMS, ENGINEERED CELLS FOR VIRAL VECTOR PRODUCTION, AND METHODS OF USE THEREOF

#11
20240082288
2024-03-14

Compositions and Methods for Altering Tissue Specificity and Improving AAV9-Mediated Gene Transfer

#12
20240067974
2024-02-29

METHOD OF ALLELE SPECIFIC SILENCING FOR THE TREATMENT OF AUTOSOMAL DOMINANT CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)

#13
20240066147
2024-02-29

AAV-MEDIATED EXPRESSION USING A SYNTHETIC PROMOTER AND ENHANCER

#14
20240066080
2024-02-29

PROTOPARVOVIRUS AND TETRAPARVOVIRUS COMPOSITIONS AND METHODS FOR GENE THERAPY

#15
20230416757
2023-12-28

SOD1 dual expression vectors and uses thereof

#16
20230416700
2023-12-28

COMPOSITIONS USEFUL IN TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY

#17
20230374546
2023-11-23

BIDIRECTIONAL DUAL PROMOTER EXPRESSION VECTORS AND USES THEREOF

#18
20230033866
2023-02-02

COMPOSITIONS AND METHODS FOR THE TARGETING OF RHODOPSIN

#19
20230013253
2023-01-19

COMPOSTIONS AND METHODS FOR NUCLEIC ACID TRANSFECTION USING CATIONIC POLYMERS AND STABILIZERS

#20
20220332792
2022-10-20

ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF

#21
20220324928
2022-10-13

Zinc Finger Protein Transcription Factors for Repressing Alpha-Synuclein Expression

#22
20220249702
2022-08-11

GENE THERAPY FOR RETINAL DISEASE

#23
20220195428
2022-06-23

OLIGONUCLEOTIDES AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION

#24
20210388332
2021-12-16

GENE EDITING SYSTEM FOR CORRECTING SPLICING DEFECTS

#25
20210348195
2021-11-11

ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN INTERNEURONS

#26
20210238257
2021-08-05

De Novo Formation of the Biliary System by Hepatocyte Transdifferentiation

#27
20210230634
2021-07-29

SynP159, a promoter for the expression of genes

#28
20210189401
2021-06-24

Method of allele specific silencing for the treatment of autosomal dominant Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

#29
20210171982
2021-06-10

IMPROVED CLINICAL PARAMETERS BY EXPRESSION OF FACTOR VIII

#30
20210145857
2021-05-20

Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer

#31
20210128750
2021-05-06

Modulation of neural pathways

#32
20210108209
2021-04-15

Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis

#33
20200377866
2020-12-03

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#34
20200308554
2020-10-01

Gene therapies for lysosomal disorders

#35
20200282080
2020-09-10

Gene therapies for lysosomal disorders

#36
20200276335
2020-09-03

Gene therapies for lysosomal disorders

#37
20200248187
2020-08-06

SOD1 dual expression vectors and uses thereof

#38
20200101099
2020-04-02

Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer

#39
20190144868
2019-05-16

Products and methods for treatment of familial amyotrophic lateral sclerosis

#40
20190083657
2019-03-21

AAV-mediated expression using a synthetic promoter and enhancer

#41
20190071651
2019-03-07

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#42
20180355377
2018-12-13

SYNP159, a promoter for the specific expression of genes in rod photoreceptors

#43
20180305717
2018-10-25

Baculovirus system for the expression of a gene therapy vector

#44
20180185405
2018-07-05

Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer

#45
20180169213
2018-06-21

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#46
20180135030
2018-05-17

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#47
20170051259
2017-02-23

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#48
20170021037
2017-01-26

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#49
20160068822
2016-03-10

RECOMBINANT VIRUS AND PREPARATIONS THEREOF

#50
20150297708
2015-10-22

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#51
20150297707
2015-10-22

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#52
20140349374
2014-11-27

Baculovirus system for the expression of a gene therapy vector

#53
20140287938
2014-09-25

Recombinant virus and preparations thereof

#54
20130323226
2013-12-05

Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer

#55
20120263756
2012-10-18

Vaccines containing canine parvovirus genetic variants

#56
20120107348
2012-05-03

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#57
20110223635
2011-09-15

Method and Composition for Controlling Gene Expression

#58
20090258396
2009-10-15

Crustaceans as production systems for therapeutic proteins

#59
20090098152
2009-04-16

Vaccines containing canine parvovirus genetic variants

#60
20090092636
2009-04-09

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#61
20090010955
2009-01-08

Vaccines containing canine parvovirus genetic variants

#62
20080226669
2008-09-18

MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS

#63
20070231347
2007-10-04

Immunization regimen with E4-deleted adenovirus prime and E1-deleted adenovirus boost

#64
20060188484
2006-08-24

Virus vectors and methods of making and administering the same

#65
20060188483
2006-08-24

Virus vectors and methods of making and administering the same